Process followed by the U.S. Food and Drug Administration (FDA)
Notice: Trying to access array offset on value of type bool in /home/onliiuxo/public_html/wp-content/themes/betheme/functions/theme-functions.php on line 1490
Notice: Trying to access array offset on value of type bool in /home/onliiuxo/public_html/wp-content/themes/betheme/functions/theme-functions.php on line 1495
Process followed by the U.S. Food and Drug Administration (FDA)
Notice: Trying to access array offset on value of type bool in /home/onliiuxo/public_html/wp-content/themes/betheme/functions/theme-functions.php on line 1490
Notice: Trying to access array offset on value of type bool in /home/onliiuxo/public_html/wp-content/themes/betheme/functions/theme-functions.php on line 1495
While the usual process followed by the U.S. Food and Drug Administration (FDA) requires that thorough clinical trials have shown the benefits of a drug before approval is granted, an accelerated approval process is possible in some cases for drugs designed to treat some serious illnesses. Discuss a solution to the problem of addressing patients’ demands to accelerate clinical trials of new medicines while ensuring that the medicines are safe.
